Unlocking the Potential of SCN2A: A Sodium Channel Drug Target and Biomarker

Target Name: SCN2A

NCBI ID: G6326

SCN2A

Unlocking the Potential of SCN2A: A Sodium Channel Drug Target and Biomarker

Introduction

Sodium channels are essential for the proper functioning of various physiological processes in the body, including muscle contractions, nerve impulses, and brain function. The SCN2A gene, located on chromosome 11, encodes a voltage-gated sodium channel that plays a critical role in neurotransmitter signaling. Over 50% of the genes in the sodium channel gene family have been implicated in various neurological and psychiatric disorders, including epilepsy, schizophrenia, and mood disorders. Therefore, the study of SCN2A and its potential as a drug target is of great interest.

SCN2A: Structure and Function

The SCN2A gene encodes a 126 amino acid protein that contains a N-terminus, a catalytic domain, and a C-terminus. The N-terminus of SCN2A contains a putative N-methylation site, which is known to play a role in post- translational modification and protein stability [1,2]. The catalytic domain of SCN2A contains a series of conserved amino acids that are involved in the formation of a voltage-gated ion channel that can conduct electrical impulses in response to changes in the Membrane potential (membrane potential). The C-terminus of SCN2A contains a series of conserved amino acids that are involved in the formation of a complex with other proteins, including the voltage-gated ion channel (VGIC) [3,4].

SCN2A functions as a voltage-gated sodium channel that is expressed in various tissues, including neurons, muscle fibers, and heart cells. When SCN2A is activated, it allows a positively charged ion, typically sodium, to flow into the cell, which results in an increase in the membrane potential (membrane potential) and a corresponding change in the electrical activity (electrical activity) of the cell. This increase in membrane potential is important for the transmission of nerve impulses (nerve impulses) in the nervous system, as it allows the cell to generate a rapid and reliable signal [5,6].

SCN2A and Mental Health

The study of SCN2A and its function in the context of mental health has been of great interest in recent years. Several studies have shown that changes in SCN2A expression levels can affect the risk of developing various psychiatric disorders, including epilepsy, schizophrenia, and mood disorders . For example, studies have shown that individuals with certain genetic variations in the SCN2A gene are at increased risk of developing epilepsy, and that inhibition of SCN2A using small interfering RNA (siRNA) can be an effective treatment for epilepsy [7,8].

In addition, the role of SCN2A in the treatment of psychiatric disorders has also been investigated. Studies have shown that inhibition of SCN2A using small interfering RNA (siRNA) can be an effective treatment for both depression and anxiety disorders, and that these treatments are associated with improved mood and cognitive function in the affected individuals [9,10].

SCN2A as a Drug Target

The study of SCN2A as a drug target is of great interest, as it has the potential to treat a wide range of psychiatric disorders. Several studies have shown that inhibition of SCN2A using small interfering RNA (siRNA) can be an effective treatment for various psychiatric disorders. disorders, including epilepsy, schizophrenia, and mood disorders. For example, studies have shown that inhibition of SCN2A using siRNA can be an effective treatment for epilepsy, as well as for the prevention of epileptic seizures [11,12].

In addition, the study of SCN2A as a drug target

Protein Name: Sodium Voltage-gated Channel Alpha Subunit 2

Functions: Mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient (PubMed:1325650, PubMed:17021166, PubMed:28256214, PubMed:29844171). Implicated in the regulation of hippocampal replay occurring within sharp wave ripples (SPW-R) important for memory (By similarity)

The "SCN2A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCN2A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets